Bioscience Trends

Papers
(The H4-Index of Bioscience Trends is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Poor emotional status increases the risk of attempted suicide for the elderly age 55 and older in Shanghai, China: A longitudinal follow-up study209
Development and validation of a machine-learning model to predict lymph node metastasis of intrahepatic cholangiocarcinoma: A retrospective cohort study133
Heparin therapy in COVID-19: Call for randomized controlled trials (RCTs)110
Effect of transcatheter arterial chemoembolization combined with lenvatinib plus anti–PD-1 antibodies in patients with unresectable hepatocellular carcinoma: A treatment with Chinese characteristics109
Corrigendum to "Shufengjiedu capsules protect against neuronal loss in olfactory epithelium and lung injury by enhancing autophagy in rats with allergic rhinitis", BioScience Trends. 2019; 13(6):530-584
Value of multidisciplinary team (MDT) in minimally invasive treatment of complex intrahepatic bile duct stones67
New progress in elucidating the relationship between cancer therapy and cardiovascular toxicity67
Effects and mechanisms of microenvironmental acidosis on osteoclast biology51
Metformin acts on the gut-brain axis to ameliorate antipsychotic-induced metabolic dysfunction49
Revealing the enhancement effect of social capital on the individual performance of core members in elderly caring organizations: A study from Anhui, China46
Rapid evolution of the COVID-19 pandemic calls for a unified public health response34
Treatment of biliary tract carcinoma over the last 30 years30
The initiation, exploration, and development of hospital-based health technology assessment in China: 2005 ‒ 202226
An innovative two-wing model for balancing the demands of inpatients with COVID-19 and general medical service in a designated hospital for COVID-19 in Shenzhen, China26
Interaction with ERp57 is required for progranulin protection against Type 2 Gaucher disease25
Formulation and interpretation of the Chinese Guidelines for Surgical Treatment of Obesity and Type 2 Diabetes Mellitus24
Focusing on development of novel sampling approaches and alternative therapies for COVID-19: Are they still useful in an era after the pandemic?21
EMG-FRNet: A feature reconstruction network for EMG irrelevant gesture recognition20
Feasibility of novel intraoperative navigation for anatomical liver resection using real-time virtual sonography combined with indocyanine green fluorescent imaging technology19
0.042999982833862